Rami Elghandour

Rami Elghandour filed 29 sales worth EUR 26,142,367, median EUR 666,735, and no purchase. The largest, EUR 8,678,475 at Arcellx, Inc., dates from February 27, 2026; next come EUR 1,470,386 on January 4, 2024 and EUR 1,240,695 on February 26, 2025, at the same issuer.

The 72 filings, published from March 11, 2016 to April 28, 2026, split between Arcellx (44, under SEE REMARKS) and Nevro Corp (28, as President & CEO). They include 23 option exercises, 13 share grants and 7 filings of another kind. Volume is 17 filings in 2016, then 6, 4 and 1 in 2017, 2018 and 2019, before rising to 3 in 2023, 9 in 2024, 18 in 2025, the busiest year, and 14 in 2026. Fourteen filings fall in the last twelve months, one of them a sale.

They appear a median of 2 days after the trade. At Arcellx, Christopher Heery has 18 open-market trades within 30 days of those of Elghandour, Michelle Gilson 12 and Kavita Patel 9; at Nevro, Michael Enxing has 10 and Michael F. Demane 8, all in the same direction.